SHARE:
aduhelm
| Variable | Question text | Label |
|---|---|---|
| ad001 | How much would you say you know about this new drug treatment for Alzheimer’s, Aduhelm (aducanumab)? | how much know aduhelm |
| ad002 | How concerned are you about the risk of Alzheimer's disease for Americans and their families? | how worried about alzheimer |
| ad003 | The scientific evidence on the efficacy of this drug for slowing the progression of Alzheimer’s disease is strong. | scientific evidence is strong |
| ad004 | Only patients with moderate or severe Alzheimer’s disease are recommended to use Aduhelm (aducanumab). | aduhelm only for patients moderate or severe alzheimer |
| ad005 | Aduhelm (aducanumab) will be administered by infusion into a vein. | Aduhelm (aducanumab) will be administered by infusion into a vein |
| ad006 | Aduhelm (aducanumab) has side effects including headache, confusion, dizziness, vision changes, or nausea. | Aduhelm (aducanumab) has side effects |
| ad007 | The price of Aduhelm (aducanumab) will be $56,000 per patient per year. | price of Aduhelm (aducanumab) will be $56,000 per patient per year |
| ad008 | Medicare and other health insurers will likely pay for the cost of Aduhelm (aducanumab) less any copayments, deductibles. | Medicare, others likely pay cost Aduhelm (aducanumab) less copayments, deductibles |
| ad009 | The FDA’s expert panel strongly endorsed approval of Aduhelm (aducanumab). | FDA's expert panel strongly endorsed approval of Aduhelm (aducanumab). |
| ad010_order | order ad010 series | |
| ad010a | Will provide important benefits to society | Will provide important benefits to society |
| ad010b | Is a major breakthrough in Alzheimer’s disease treatment | Is a major breakthrough in Alzheimer’s disease treatment |
| ad010c | Will be costly to Medicare | Will be costly to Medicare |
| ad010d | Will be expensive for patients | Will be expensive for patients |
| ad010e | Has serious side effects | Has serious side effects |
| ad010f | Increases the chance I will seek screening or testing for cognitive impairment | Increases the chance I will seek screening or testing for cognitive impairment |
| ad011 | I would want to receive Aduhelm if I had Alzheimer's disease | want to receive aduhelm |
| ad012 | You said you ^FL_ad012 receive the drug treatment Aduhelm if you had Alzheimer’s disease. Please check the reasons why you made that choice: | Drug will not be effective |
| ad_order | overall question order |